EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Countering the effector functions of ESAT ‐6 protein in Mycobacterium tuberculosis : strategies for developing antimycobacterial therapeutics

Akshay Girish Manikoth, Manoj Kumar Bisht, Sudip Ghosh, Sangita Mukhopadhyay iD

The FEBS Journal · 2025

DOI: 10.1111/febs.70084 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FEBS Journal, 2025. Verfasst von Akshay Girish Manikoth und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Cell Biology, BRIC-Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad, India. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Antigens, Bacterial, Bacterial Proteins, Tuberculosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 137 Literaturangaben. Gefördert von: Science and Engineering Research Board, Council of Scientific and Industrial Research (CSIR), Govt. of India, Indian Council of Medical Research (ICMR), Govt. of India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis is an infectious disease primarily caused by the bacterium Mycobacterium tuberculosis . This bacterium infects about 10 million and kills about 1.6 million people annually. M. tuberculosis infects macrophages and manipulates its defense functions to safely replicate inside it. Sequence comparison between an attenuated Mycobacterium bovis bacille Calmette‐Guérin (BCG) strain and M. tuberculosis identified a region of difference 1 (RD1) which encodes highly antigenic proteins, such as early secretory antigenic target‐6 (ESAT‐6) and 10‐kDa culture filtrate protein (CFP‐10), and proteins that make up the ATP‐dependent secretory apparatus. Various studies suggest that the ESAT‐6 protein counteracts various innate and adaptive immune functions of the host and is involved in regulating mycobacterial virulence. This review focuses on how ESAT‐6 manipulates host immune responses that are critical for the survival and virulence of M. tuberculosis . We also discuss the possible therapeutic management of tuberculosis by targeting ESAT‐6.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisAntigens, BacterialBacterial ProteinsTuberculosisAntitubercular AgentsHumansAnimalsVirulence

Stichwörter der Autor:innen

Mycobacterium tuberculosisESAT‐6 proteinT‐cell immunomodulationmacrophagetherapeutic managementvirulence

Substanzen

ESAT-6 protein, Mycobacterium tuberculosisAntigens, BacterialBacterial ProteinsAntitubercular Agents

Autor:innen und Institutionen

  • Laboratory of Molecular Cell Biology, BRIC-Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad, India.
  • Graduate Studies, Manipal Academy of Higher Education, India.
  • Molecular Biology Division, ICMR-National Institute of Nutrition, Hyderabad, India.

ORCID-Profile: Sangita Mukhopadhyay

Förderung

  • Science and Engineering Research Board
  • Council of Scientific and Industrial Research (CSIR), Govt. of India
  • Indian Council of Medical Research (ICMR), Govt. of India
  • Department of Biotechnology (DBT), Ministry of Science and Technology, Govt of India
  • Indian Council of Medical Research

Zitieren

APA

Manikoth, A. G., Bisht, M. K., Ghosh, S., & Mukhopadhyay, S. (2025). Countering the effector functions of ESAT ‐6 protein in Mycobacterium tuberculosis : strategies for developing antimycobacterial therapeutics. The FEBS Journal. https://doi.org/10.1111/febs.70084

Vancouver

Manikoth AG, Bisht MK, Ghosh S, Mukhopadhyay S. Countering the effector functions of ESAT ‐6 protein in Mycobacterium tuberculosis : strategies for developing antimycobacterial therapeutics. The FEBS Journal. 2025. doi:10.1111/febs.70084

BibTeX
@article{Manikoth2025,
  author = {Manikoth, Akshay Girish and Bisht, Manoj Kumar and Ghosh, Sudip and Mukhopadhyay, Sangita},
  title = {Countering the effector functions of ESAT ‐6 protein in Mycobacterium tuberculosis : strategies for developing antimycobacterial therapeutics},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.70084}
}
Kostenlos starten →